October 25, 2014 8:00 PM ET

Biotechnology

Company Overview of KaloBios Pharmaceuticals, Inc.

Key Executives for KaloBios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David W. Pritchard 6 RelationshipsChief Executive Officer, President and Director60
Jeng-Horng Her Ph.D.9 RelationshipsCo-Founder and Director of Research--
Herbert C. Cross No RelationshipsChief Financial Officer and Principal Accounting Officer42
Charles J. Democko No RelationshipsSenior Vice President of Regulatory Affairs and Quality59
Anne Borgman Hagey M.D.No RelationshipsAssociate Chief Medical Officer46
View More Key Executives

KaloBios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ted W. Love M.D. 103 RelationshipsGlobal Blood Therapeutics, Inc.55
David W. Pritchard 6 RelationshipsKaloBios Pharmaceuticals, Inc.60
James W. Larrick Ph.D. 40 RelationshipsKaloBios Pharmaceuticals, Inc.--
Raymond M. Withy Ph.D. 6 RelationshipsKaloBios Pharmaceuticals, Inc.59
Denise M. Gilbert Ph.D. 43 RelationshipsCytokinetics, Incorporated56
View All Board Members

KaloBios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Denise M. Gilbert43 Relationships3 Executives
Compensation Committee Gary A. Lyons35 Relationships3 Executives
Nominating Committee Ph.D.Raymond M. Withy6 Relationships2 Executives
Corporate Governance Committee Ph.D.Raymond M. Withy6 Relationships2 Executives
Advisory Board Ph.D.James W. Larrick40 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$417.5K
417.5K
364.7K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$417.5K
417.5K
21.4M
Compensation as of Fiscal Year 2013
KaloBios Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Suominen Corporation Announces Board Changes
October 24, 2014 5:30 AM ET
Procter & Gamble Announces Executive Changes
October 23, 2014 12:00 AM ET
McBride Announces Job Cuts; Chris Smith to Join as Finance Director, Effective from January 7, 2015
October 21, 2014 7:34 AM ET
Colgate-Palmolive Co. Announces Executive Changes
October 16, 2014 8:23 PM ET
Hindustan Unilever Limited Appoints Kalpana Morparia as an Independent Director on the Board
October 09, 2014 12:28 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.